Literature DB >> 23634372

What is the standard approach to assessment of an unprovoked seizure in an adult?: UNITED STATES.

Gregory D Cascino1.   

Abstract

A 34-year-old man experienced a single unprovoked generalized tonic-clonic seizure in the earlier morning hours while asleep. His spouse was awakened during the respiratory alteration and the repetitive movements. The patient was in excellent health without a prior history of seizures or remote symptomatic neurologic disease. There was a history of migraine headaches and mild closed head trauma as a child. He was receiving no prescription drugs. The family history was negative for epilepsy. Upon evaluation in the emergency department, a CT of the head was normal. The patient was described as being "postictal" on examination. An EEG study several hours after the seizure showed bitemporal, nonspecific slowing without definite epileptiform activity. An MRI head was performed the following day and was unremarkable. The patient was referred by the emergency room physician for an outpatient neurologic consultation.

Entities:  

Year:  2012        PMID: 23634372      PMCID: PMC3613209          DOI: 10.1212/CPJ.0b013e318279ad2c

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  4 in total

1.  Risk of recurrent seizures after two unprovoked seizures.

Authors:  W A Hauser; S S Rich; J R Lee; J F Annegers; V E Anderson
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

Review 2.  Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota.

Authors:  W A Hauser; J F Annegers; W A Rocca
Journal:  Mayo Clin Proc       Date:  1996-06       Impact factor: 7.616

Review 3.  Risk of recurrence after a first unprovoked seizure.

Authors:  Anne T Berg
Journal:  Epilepsia       Date:  2008       Impact factor: 5.864

4.  Single Unprovoked Seizures.

Authors:  Susan T. Herman
Journal:  Curr Treat Options Neurol       Date:  2004-05       Impact factor: 3.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.